Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study
勘误表：抗 CD3 单克隆抗体 (Foralumab) 鼻腔给药可减少轻度至中度 COVID-19 患者的肺部炎症和血液炎症生物标志物：一项试点研究
期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2021.815812
Thais G Moreira, Kimble T F Matos, Giovana S De Paula, Thais M M Santana, Raquel G Da Mata, Fernando C Pansera, Andre S Cortina, Marcelle G Spinola, Clare M Baecher-Allan, Gerson D Keppeke, Jules Jacob, Vaseem Palejwala, Karen Chen, Saef Izzy, Brian C Healey, Rafael M Rezende, Rogerio A Dedivitis, K
免疫
鼻炎
Immunology/Inflammation
